Skip to content

Study on Medical Device

A Real world, prospective, observational, Investigator Initiated Trial to evaluate early discharge following Angio-Sealâ?¢ vascular closure device in patients undergoing percutaneous coronary intervention

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033309
Enrollment
50
Registered
2021-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I779- Disorder of arteries and arterioles, unspecified

Interventions

None listed

Sponsors

Aditya Birla Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients meeting with following criteria to be included in the study: 1) Patients > 18 years of age 2) Patients suitable for percutaneous coronary intervention through femoral approach 3) Angio-Seal • deployment will be as the IFU approved for India. 4) Patient or Legally acceptable representative of patient willing to sign an Informed Consent Form indicating that they understand the purpose of and the procedures required for the trial and are willing to participate in the study

Exclusion criteria

Exclusion criteria: Patients meeting with following criteria to be excluded from the study: 1) Pregnant/ lactating females 2) Patients having known allergy to collagen and/or collagen products, or polyglycolic or polylactic acid polymers 3) Patients with ST elevation MI 4) Patients with Heart failure 5) Presence of any other clinically significant disease or laboratory findings that in the Investigatorâ??s opinion may affect the study outcomes.

Design outcomes

Primary

MeasureTime frame
Time to Discharge post procedure in hours (Clinicians prescription notes will be taken as Discharge pointTimepoint: At baseline

Secondary

MeasureTime frame
1) Incidence of vascular access site complications i.e. composite of hematoma, pseudoaneurysm, arteriovenous fistula 2) Time to ambulation 3) Time to haemostasis Timepoint: Post Procedure

Countries

India

Contacts

Public ContactDr Rajesh Surendra Badani

Aditya Birla Memorial Hospital

iitabmh2021@gmail.com9823818400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026